Universe · entity
RA CAPITAL MANAGEMENT, L.P.
Institutional manager (13F) · CIK 1346824
13F holdings · as of 2026-03-31 · top 50 · reported portfolio $8.9B
| # | Issuer | Value | Shares |
|---|---|---|---|
| 1 | ASCENDIS PHARMA A/S - ADR | $2.4B | 10,281,496 |
| 2 | VAXCYTE INC | $667M | 11,474,599 |
| 3 | RHYTHM PHARMACEUTICALS INC | $580M | 6,666,837 |
| 4 | TYRA BIOSCIENCES INC | $467M | 12,198,625 |
| 5 | SIONNA THERAPEUTICS INC | $397M | 9,905,045 |
| 6 | EDGEWISE THERAPEUTICS INC | $328M | 10,428,437 |
| 7 | NEWAMSTERDAM PHARMA CO NV | $306M | 9,550,191 |
| 8 | NUVALENT INC-A | $260M | 2,534,145 |
| 9 | DIANTHUS THERAPEUTICS INC | $219M | 2,611,733 |
| 10 | MINERALYS THERAPEUTICS INC | $208M | 7,692,750 |
| 11 | SPYGLASS PHARMA INC | $208M | 8,021,117 |
| 12 | WAVE LIFE SCIENCES LTD | $196M | 26,975,505 |
| 13 | SEPTERNA INC | $168M | 6,995,858 |
| 14 | DISC MEDICINE INC | $157M | 2,450,221 |
| 15 | JANUX THERAPEUTICS INC | $156M | 11,189,693 |
| 16 | BIOCRYST PHARMACEUTICALS INC | $151M | 15,827,186 |
| 17 | BICARA THERAPEUTICS INC | $144M | 7,255,993 |
| 18 | PRAXIS PRECISION MEDICINES I | $120M | 373,787 |
| 19 | GH RESEARCH PLC | $108M | 7,676,697 |
| 20 | ZAI LAB LTD-ADR | $107M | 5,707,262 |
| 21 | TAYSHA GENE THERAPIES INC | $105M | 23,555,648 |
| 22 | VOR BIOPHARMA INC | $96M | 5,404,998 |
| 23 | GERON CORP | $95M | 63,771,366 |
| 24 | ARS PHARMACEUTICALS INC | $87M | 10,860,977 |
| 25 | SAREPTA THERAPEUTICS INC | $85M | 3,902,596 |
| 26 | SPYRE THERAPEUTICS INC | $82M | 1,621,620 |
| 27 | EVOMMUNE INC | $80M | 3,494,638 |
| 28 | CLIMB BIO INC | $77M | 11,300,939 |
| 29 | SOLID BIOSCIENCES INC | $67M | 9,339,978 |
| 30 | ARTIVA BIOTHERAPEUTICS INC | $63M | 9,853,302 |
| 31 | DAMORA THERAPEUTICS INC | $62M | 2,399,310 |
| 32 | XENCOR INC | $59M | 4,897,237 |
| 33 | LB PHARMACEUTICALS INC | $54M | 2,208,604 |
| 34 | JADE BIOSCIENCES INC | $52M | 3,671,083 |
| 35 | ACUMEN PHARMACEUTICALS INC | $50M | 20,992,669 |
| 36 | 4D MOLECULAR THERAPEUTICS IN | $47M | 5,049,779 |
| 37 | FULCRUM THERAPEUTICS INC | $46M | 6,053,960 |
| 38 | CAPRICOR THERAPEUTICS INC | $46M | 1,507,844 |
| 39 | CENTURY THERAPEUTICS INC | $40M | 17,754,430 |
| 40 | OLEMA PHARMACEUTICALS INC | $39M | 2,600,000 |
| 41 | LENZ THERAPEUTICS INC | $38M | 4,178,823 |
| 42 | MONOPAR THERAPEUTICS INC | $37M | 667,207 |
| 43 | PEPGEN INC | $36M | 20,064,545 |
| 44 | DESIGN THERAPEUTICS INC | $32M | 2,972,973 |
| 45 | MIRUM PHARMACEUTICALS INC | $29M | 318,554 |
| 46 | BIOAGE LABS INC | $29M | 1,650,648 |
| 47 | LEXEO THERAPEUTICS INC | $29M | 5,000,000 |
| 48 | ASSEMBLY BIOSCIENCES INC | $28M | 1,020,410 |
| 49 | REZOLUTE INC | $28M | 9,180,000 |
| 50 | AKTIS ONCOLOGY INC | $27M | 1,503,084 |
Source: sec_edgar_13f · public regulatory · retrieved 2026-06-29. Public SEC data; no contact information.